Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 05-19-2010, 03:18 PM #1
imark3000 imark3000 is offline
Member
 
Join Date: Nov 2007
Location: Calgary-Canada
Posts: 821
15 yr Member
imark3000 imark3000 is offline
Member
 
Join Date: Nov 2007
Location: Calgary-Canada
Posts: 821
15 yr Member
Default Parallel brainstem circuit discovery suggests new path in Parkinson's research

After 50 or so years of dopamine theory, PD proves more illusive.
Imad

Parallel brainstem circuit discovery suggests new path in Parkinson's research
Chicago and Montreal researchers studying the lowly lamprey eel have identified an overlooked nervous system pathway running parallel to known brainstem locomotor command circuitry in vertebrates such as birds, fishes and mammals.

The finding is reported in Nature Neuroscience, online May 16, and highlighted in the magazine's "news and views" section.

Simon Alford, University of Illinois at Chicago professor of biological sciences and the article's corresponding author, said the role of a neurotransmitter associated with this parallel pathway may also suggest new research directions for treating Parkinson's disease.

Alford, along with his former graduate student and lead author Roy Smetana, now a University of Pittsburgh resident in psychiatry, worked with Université de Montréal and Université de Québec à Montréal neurobiologist Réjean Dubuc and his post-doctoral researcher Laurent Juvin in trying to sort out how the neurotransmitter analog muscarine modifies sensory information going to the brain.

Their work determined that muscarine stimulated neural activity, leading to locomotion in the laboratory lampreys.

The group focused its attention on a collection of brainstem neurons that tell the spinal cord to generate motor output that enables walking and other locomotion.

"We started looking at this group of neurons, which in the lamprey are conveniently very large, so they're easy to plant electrodes and record from," said Alford. "We discovered the muscarinic excitation was not working on these cells, but on a previously unknown group of cells within the brainstem."
imark3000 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
paula_w (05-19-2010)

advertisement
Old 05-19-2010, 07:06 PM #2
Fiona Fiona is offline
Member
 
Join Date: Oct 2006
Posts: 492
15 yr Member
Fiona Fiona is offline
Member
 
Join Date: Oct 2006
Posts: 492
15 yr Member
Default

Thanks for being on it, Imad, as always!

Hello, hello, from White Rats to White Coats - I've been saying, it's not just about the dopamine...
Fiona is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
imark3000 (05-19-2010)
Old 05-19-2010, 07:07 PM #3
lindylanka lindylanka is offline
Senior Member
 
Join Date: Sep 2006
Posts: 1,271
15 yr Member
lindylanka lindylanka is offline
Senior Member
 
Join Date: Sep 2006
Posts: 1,271
15 yr Member
Default Thanks for this post......

The role of the neurotransmitter acetylcholine may ultimately suggest new Parkinson's disease treatments. While a key Parkinson's symptom is tremor, an advanced stage symptom is the inability to start a movement, such as walking. Symptoms associated with Parkinson's can be helped by reducing acetylcholine-mediated neurotransmission in the brain, but little work has focused on brainstem muscarine receptors in this disease.

I tried to talk about exactly this at my last appointment and was flatly told that anticholinergic medication is 'very old fashioned and out of date' . I have read that such medications were a mainstay of PD treatment prior to l-dopa, and there must have been good reasons for that. I took such three drugs for different reason than PD, over nearly 4 years, they are regularly prescribed for other conditions, and discontinued them due to side effects, and my query was because I had lost fluidity of movement since stopping them.

The consultant who prescribed them was aware that they enhanced mobility in PD.

And then this crops up!

Paula, I know you have been looking at this for ages.....

Thank you so much for this post, Imad.

Lindy
lindylanka is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
imark3000 (05-19-2010)
Old 05-19-2010, 08:08 PM #4
paula_w paula_w is offline
In Remembrance
 
Join Date: Aug 2006
Location: Florida
Posts: 3,904
15 yr Member
paula_w paula_w is offline
In Remembrance
 
Join Date: Aug 2006
Location: Florida
Posts: 3,904
15 yr Member
Default gestalt

here's the public press release all put together:
Public release date: 19-May-2010

Contact: Paul Francuch
francuch@uic.edu
312-996-3457
University of Illinois at Chicago

Parallel brainstem circuit discovery suggests new path in Parkinson's research


Chicago and Montreal researchers studying the lowly lamprey eel have identified an overlooked nervous system pathway running parallel to known brainstem locomotor command circuitry in vertebrates such as birds, fishes and mammals.
The finding is reported in Nature Neuroscience, online May 16, and highlighted in the magazine's "news and views" section.
Simon Alford, University of Illinois at Chicago professor of biological sciences and the article's corresponding author, said the role of a neurotransmitter associated with this parallel pathway may also suggest new research directions for treating Parkinson's disease.
Alford, along with his former graduate student and lead author Roy Smetana, now a University of Pittsburgh resident in psychiatry, worked with Université de Montréal and Université de Québec à Montréal neurobiologist Réjean Dubuc and his post-doctoral researcher Laurent Juvin in trying to sort out how the neurotransmitter analog muscarine modifies sensory information going to the brain.
Their work determined that muscarine stimulated neural activity, leading to locomotion in the laboratory lampreys.
The group focused its attention on a collection of brainstem neurons that tell the spinal cord to generate motor output that enables walking and other locomotion.
"We started looking at this group of neurons, which in the lamprey are conveniently very large, so they're easy to plant electrodes and record from," said Alford. "We discovered the muscarinic excitation was not working on these cells, but on a previously unknown group of cells within the brainstem."
What's more, these newly discovered brainstem neurons showed what Alford called a "very odd response" to the muscarine.
"Instead of just turning on -- like a synapse turns on a neuron and makes it fire -- when you put muscarine on these cells, they turn on and stay on" for a minute or longer which he said for a neurological reaction can be a very long time.
The researchers discovered the actual brain neurotransmitter that activates muscarine receptors -- another chemical, acetylcholine -- sends a signal to these newly discovered brainstem neurons, switching them on for the lengthy minute or so durations.
Alford said the finding opens up new insights into animal locomotion.
"It's a system for turning on your locomotor system and making you walk or run in a very coordinated, straight-line fashion sustaining locomotion for a considerable time," he said. "This simply was not known to exist before we discovered it."
The role of the neurotransmitter acetylcholine may ultimately suggest new Parkinson's disease treatments. While a key Parkinson's symptom is tremor, an advanced stage symptom is the inability to start a movement, such as walking. Symptoms associated with Parkinson's can be helped by reducing acetylcholine-mediated neurotransmission in the brain, but little work has focused on brainstem muscarine receptors in this disease.
"This may be a backdoor finding into a secondary effect of Parkinson's disease that's not well studied because most research emphasis has been on dopamine and the basal ganglia, a different neurotransmitter and region of the brain," Alford said.

###

Major funding for the research came from the National Institute of Neurological Disorders and Stroke, and the Canadian Institutes of Health Research.

http://www.eurekalert.org/pub_releas...-pbc051910.php#
__________________
paula

"Time is not neutral for those who have pd or for those who will get it."

Last edited by paula_w; 05-19-2010 at 08:27 PM.
paula_w is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
imark3000 (05-19-2010)
Old 05-19-2010, 09:41 PM #5
Conductor71's Avatar
Conductor71 Conductor71 is offline
Senior Member
 
Join Date: Jul 2009
Location: Michigan
Posts: 1,474
10 yr Member
Conductor71 Conductor71 is offline
Senior Member
Conductor71's Avatar
 
Join Date: Jul 2009
Location: Michigan
Posts: 1,474
10 yr Member
Default Even more to try and figure out...

Hi all,

I am pretty sure this is where the idea that coffee may be neuroprotective comes from this largely underexplored side of PD. I have read anecdotal evidence that caffeine alleviates symptoms in some- not happening for me, but there are studies going on now. Same with targeting nicotinic receptors and whole idea behind smoking... -Laura

This excerpt is from a new find The IUPHAR Database http://www.iuphar-db.org/DATABASE/Fa...ard?familyId=2 (International Union of Pharmacology) of an association that really seems to be providing good information on receptors, disease, and emerging drug treatments:


Muscarinic receptors as drug targets

In line with a greater understanding of the neuromodulatory role of muscarinic receptors has come a greater focus on the possibility that this receptor family may be effective therapeutic targets in a number of neurological and psychiatric diseases [231]. Historically this focus has centred on Alzheimer's disease, which is associated with a loss of cholinergic innervation in the cerebral cortex and hippocampus, and is currently treated by enhancing cholinergic transmission via pharmacological inhibition of cholinesterase activity[234]. Whereas for many years this treatment was thought to have its beneficial affects by stimulation of the M1-muscarinic receptor subtype [235], work on the M1-receptor knockout mice has suggested that this receptor subtype may not play such an important role in cognition as previously thought [231]. Thus, novel anti-Alzheimer drugs that target other muscarinic receptor subtypes, such as the M2-, M4- and M5-muscarinic receptors, are now under more intense consideration. Interestingly, muscarinic receptor modulation of dopaminergic transmission has provided the impetus for the development of muscarinic receptor ligands in the treatment of schizophrenia and Parkinson's disease [231]. In both cases the focus has been on the M1 and M4-muscarinic receptors, where it has been indicated that agonists to these receptors might be beneficial in schizophrenia and antagonists are likely to be of benefit in Parkinson's disease.
Conductor71 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
imark3000 (05-19-2010)
Old 05-20-2010, 09:09 AM #6
Fiona Fiona is offline
Member
 
Join Date: Oct 2006
Posts: 492
15 yr Member
Fiona Fiona is offline
Member
 
Join Date: Oct 2006
Posts: 492
15 yr Member
Default

I've been experimenting with coffee baths - your skin absorbs stuff apparently even more effectively in some cases, right? I think they do help.
Fiona is offline   Reply With QuoteReply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
New Research discovery olsen Parkinson's Disease 1 11-04-2009 01:22 PM
ALS Research Update / New Gene Mutation Discovery BobbyB ALS News & Research 0 02-26-2009 07:22 PM
Brainstem implant turns off dad's 8 years of Parkinson's tremors lou_lou Parkinson's Disease 0 07-10-2008 10:39 AM
New Data Suggests Current Approach to Drug Discovery for Lou Gehrig's Disease Be Re-E BobbyB ALS News & Research 0 07-18-2007 08:27 AM
Parkinson's disease: Treatment breakthrough in mice opens new path Stitcher Parkinson's Disease 1 02-09-2007 11:53 PM


All times are GMT -5. The time now is 01:55 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.